University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
68
About the Report
About the Report
Summary
University of Pittsburgh (Pitt) is an educational research institute that offers undergraduate, graduate and professional programs. The institute provides academic courses in different fields such as business, information sciences, health and rehabilitation, information sciences, engineering, environmental and occupational health, epidemiology, nursing, bioinformatics, biological sciences, pharmacy, arts, social sciences, law, medicine, public and international affairs. It conducts research in the areas such as aging, bioengineering, computer modeling, drug discovery, global health, humanities, international studies, and others. Pitt collaborates with universities for its research activities. The institute is member of the Association of American Universities. Pitt is headquartered in Pittsburgh, Pennsylvania, the US.
University of Pittsburgh-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
University of Pittsburgh, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Pittsburgh, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Pittsburgh, Medical Devices Deals, 2012 to YTD 2018 10
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
University of Pittsburgh, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Evolent Health Raises USD 101.3 Million In Series B Financing 13
Partnerships 15
Globin Solutions Enters into Licensing Agreement with University of Pittsburgh Innovation Institute 15
Immunovia Enters into Agreement with University of Pittsburgh 16
Aires Pharma Enters into Agreement with University of Pittsburgh 17
University of Pittsburgh and Bayer Form Research Collaboration Agreement 18
University of Pittsburgh Cancer Institute Enters into Contract with National Cancer Institute 19
American Gene Technologies Partners with University of Pittsburgh 20
NanoViricides Enters into Research Agreement with University of Pittsburgh 21
GeoVax Labs Enters into Research Agreement with University of Pittsburgh 22
Licensing Agreements 23
Inmune Bio Enters into Licensing Agreement with University of Pittsburgh 23
Koutif Therapeutics Enters into Licensing Agreement with University of Pittsburgh 24
XW Labs Enters into Licensing Agreement with University of Pittsburgh 25
BioTime Enters into Licensing Agreement with University of Pittsburgh Medical Center 26
NuvOx Pharma Enters into Licensing Agreement with University of Pittsburgh 27
Asana Medical Enters into Licensing Agreement with University of Pittsburgh 28
Oxis Biotech Amends Option Agreement with University of Pittsburgh to License Certain Patents 29
Oxis Biotech Amends Licensing Agreement with University of Pittsburgh 30
DiaVacs Enters into Licensing Agreement with University Of Pittsburgh 31
iBio Enters into Licensing Agreement with University of Pittsburgh 32
Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For EphA2 33
Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For SL-701 34
ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 35
Equity Offering 36
Globin Solutions Spun Out from University of Pittsburgh Innovation Institute 36
Evolent Health Prices Secondary Offering of Class A Shares for USD159.4 Million 37
Acquisition 39
University of Pittsburgh Medical Acquires Family Hospice and Palliative Care 39
MedCare Equipment Acquires Great Lakes Home Healthcare Services From UPMC Hamot 40
University of Pittsburgh-Key Competitors 41
University of Pittsburgh-Key Employees 42
University of Pittsburgh-Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 46
Government and Public Interest 46
Aug 30, 2018: Jewish Healthcare foundation approves over USD 1 million in grants 46
Aug 21, 2018: Pitt Doctor Gets Grant to Evaluate Self-Management Approach to Chronic Pain in HIV Patients 48
Jul 25, 2018: CurePSP supports four new studies through its venture grants program 49
Jul 02, 2018: Barone Gibbs and Collaborators Awarded USD 3.4 million from NIH to Study Sitting and Blood Pressure 50
Feb 27, 2018: Multiple Types of Delirium in the ICU Indicate High Risk for Long-Term Cognitive Decline, Study Finds 51
Jan 19, 2018: Researchers Analyze Big Data, Aim for Lung Disease Precision Treatment Improvement 52
Dec 20, 2017: Smartphone App Shows Promise Monitoring Chemotherapy Patients 54
Dec 13, 2017: IBBR Awarded NIH Grant to Investigate Body's T-Cell Mechanism of Attack 55
Nov 15, 2017: Wider sampling of tumor tissues may guide drug choice, improve outcomes 56
Nov 14, 2017: Shining a light on the nervous system to thwart disease 58
Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 59
Sep 08, 2017: Identification of new protein function that activates the harmful protein dissolution in the cell 62
May 09, 2017: Precision medicine improves treatment outcomes for some pancreatic cancer patients 64
Other Significant Developments 65
Aug 15, 2018: Healthcare Innovators professional society reaches member goal of 33 top industry executives for nationwide council 65
Aug 15, 2018: 'BOOST-3' Trial Seeks to Improve Outcomes After Severe Traumatic Brain Injury 66
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68
List of Figure
List of Figures
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Pittsburgh, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
University of Pittsburgh, Pharmaceuticals & Healthcare, Key Facts 2
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Pittsburgh, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Pittsburgh, Deals By Therapy Area, 2012 to YTD 2018 9
University of Pittsburgh, Medical Devices Deals, 2012 to YTD 2018 10
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Evolent Health Raises USD 101.3 Million In Series B Financing 13
Globin Solutions Enters into Licensing Agreement with University of Pittsburgh Innovation Institute 15
Immunovia Enters into Agreement with University of Pittsburgh 16
Aires Pharma Enters into Agreement with University of Pittsburgh 17
University of Pittsburgh and Bayer Form Research Collaboration Agreement 18
University of Pittsburgh Cancer Institute Enters into Contract with National Cancer Institute 19
American Gene Technologies Partners with University of Pittsburgh 20
NanoViricides Enters into Research Agreement with University of Pittsburgh 21
GeoVax Labs Enters into Research Agreement with University of Pittsburgh 22
Inmune Bio Enters into Licensing Agreement with University of Pittsburgh 23
Koutif Therapeutics Enters into Licensing Agreement with University of Pittsburgh 24
XW Labs Enters into Licensing Agreement with University of Pittsburgh 25
BioTime Enters into Licensing Agreement with University of Pittsburgh Medical Center 26
NuvOx Pharma Enters into Licensing Agreement with University of Pittsburgh 27
Asana Medical Enters into Licensing Agreement with University of Pittsburgh 28
Oxis Biotech Amends Option Agreement with University of Pittsburgh to License Certain Patents 29
Oxis Biotech Amends Licensing Agreement with University of Pittsburgh 30
DiaVacs Enters into Licensing Agreement with University Of Pittsburgh 31
iBio Enters into Licensing Agreement with University of Pittsburgh 32
Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For EphA2 33
Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For SL-701 34
ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 35
Globin Solutions Spun Out from University of Pittsburgh Innovation Institute 36
Evolent Health Prices Secondary Offering of Class A Shares for USD159.4 Million 37
University of Pittsburgh Medical Acquires Family Hospice and Palliative Care 39
MedCare Equipment Acquires Great Lakes Home Healthcare Services From UPMC Hamot 40
University of Pittsburgh, Key Competitors 41
University of Pittsburgh, Key Employees 42
University of Pittsburgh, Other Locations 43
University of Pittsburgh, Subsidiaries 43
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.